CSTL Castle Bio: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan

Quarterly EPS growth demonstrates the resilience of Castle Biosciences (CSTL), whose position is strengthened by patents and Medicare trust. Process robotization utilizing AI minimizes gene analysis errors, while high-demand dermatology tests reduce the number of unnecessary surgical interventions. Meanwhile, -674.80 serves as the current parameter value, allowing the market to filter out noise and assess the real dynamics of earnings per share.

CSTL: Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Castle Biosciences, Inc. 04.07.2022 - 13.11.2026

Ringkesan rincian data analitis Castle Bio (CSTL)

- rega saham lan prakiraan rega para ahli:

Rega saham Castle Biosciences, Inc.|CSTL - Prakiraan konsensus analis

- data kapitalisasi saham perusahaan:

Nilai pasar Castle Biosciences Corp|CSTL - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham Castle Biosciences|CSTL - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku castlebiosciences.com|CSTL - Gunggung Aset Perusahaan

- indikator beban utang lan likuiditas:

Total Utang marang Modal Castle Biosciences|CSTL - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Castle Biosciences|CSTL - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Castle Biosciences Corp|CSTL - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Castle Biosciences|Likuiditas cepet castlebiosciences.com

- informasi bathi lan kelipatan valuasi:

CSTL - Asil keuangan resik|Bathi mangsa ngarep Castle Biosciences|CSTL - Rasio rega pasar marang bathi resik|Rega marang bathi mangsa ngarep Castle Biosciences Corp|CSTL - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Castle Biosciences Corp|CSTL - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Castle Biosciences|CSTL - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan castlebiosciences.com|CSTL - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Castle Biosciences

Analisis kabeh metrik perusahaan:Castle Biosciences, Inc. - CSTL

Castle Biosciences' resilience to market shocks is driven by the stability of its cash flows. The implementation of molecular tests in oncodermatology creates inertial demand, ensuring predictable revenue. The quarter-over-quarter EPS dynamics measure the rate of change in net income per share relative to the previous period. Growth in this metric confirms the effectiveness of the business scaling. It is critical for investors to compare current values with the historical trend to assess overbought risks.

Pesaing utama